Recursion (RXRX) Climbs 9.5% Ahead of Next Week’s Business Updates
Corroborated by 2 sources from 2 publishers
globalhealth2d ago
TL;DR
Recursion Pharmaceuticals Inc Recursion Pharma director Christopher Gibson sells $144,800 in stock.
Sources
1
Yahoo Finance News
https://finance.yahoo.com/markets/stocks/articles/recursion-rxrx-climbs-9-5-011512355.html
3d ago
2
Investing.com News
https://www.investing.com/news/insider-trading-news/recursion-pharma-director-christopher-gibson-sells-144800-in-stock-93CH-4729287
2d ago
3
Investing.com News
https://www.investing.com/news/insider-trading-news/recursion-pharmaceuticals-ceo-najat-khan-sells-84459-in-rxrx-stock-93CH-4729290
2d ago